FDA approves trial for Exalenz's spectroscopy-based liver-assessment system

July 23, 2008 -- The U.S. Food and Drug Administration (FDA) has given Exalenz Bioscience Ltd. (Modiin, Israel) (TASE:EXEN) approval to begin Phase III clinical trials for its BreathID diagnostic system. BreathID, which incorporates proprietary technologies such as MCS (Molecular Correlation Spectroscopy), enables the assessment of liver function (hepatic impairment), gastric emptying, and the detection of the Helicobacter pylori bacteria.

According to the Israeli news outlet Globes, Exalenz will begin the trial in next month and conclude in March 2009; the trial will include 412 patients at 12 large medical centers in the U.S. as well as at Hadassah Medical Organization in Jerusalem.

Exalenz believes that this is the largest clinical trial of its kind ever conducted by an Israeli company. The trial aims to replicate the results of its Phase II clinical trial in Israel and Europe, which was completed a few months ago.

Exalenz estimates the potential market for its BreathID diagnostic device for liver damage at hundreds of millions of dollars.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Confocal microscopy method best identifies melanoma on head, neck

A team of researchers identified lesions for which reflectance confocal microscopy (RCM) performs better in terms of diagnostic accuracy.

CMOS camera for medical imaging, low-light microscopy by IDS Imaging

The UI-3860LE CMOS camera targets medical imaging and low-light microscopy, among other applications.

SalutarisMD to introduce minimally invasive ophthalmic device for wet AMD therapy

SalutarisMD has developed an investigational ophthalmic treatment for wet age-related macular degeneration (AMD).

NanoScope receives grant for exploring ultrafast laser-based therapeutic gene delivery

A highly photosensitive opsin allows stimulation of retinal cells for restoring vision in patients with retinitis pigmentosa.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS